These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19911018)

  • 1. Effect of intravitreal ranibizumab in avascular pigment epithelial detachment.
    Ritter M; Bolz M; Sacu S; Deák GG; Kiss C; Pruente C; Schmidt-Erfurth UM
    Eye (Lond); 2010 Jun; 24(6):962-8. PubMed ID: 19911018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of retinal pigment epithelial detachment associated with exudative age-related macular degeneration following intravitreal ranibizumab therapy.
    Khetpal V; Heimmel MR; Rao SK; Scott IU; Greenberg PB
    Acta Ophthalmol; 2009 Feb; 87(1):115-6. PubMed ID: 18937807
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration.
    Bolz M; Simader C; Ritter M; Ahlers C; Benesch T; Prünte C; Schmidt-Erfurth U
    Br J Ophthalmol; 2010 Feb; 94(2):185-9. PubMed ID: 19692384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration.
    Ahlers C; Golbaz I; Stock G; Fous A; Kolar S; Pruente C; Schmidt-Erfurth U
    Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab for retinal angiomatous proliferation in age-related macular degeneration.
    Atmani K; Voigt M; Le Tien V; Querques G; Coscas G; Soubrane G; Souied EH
    Eye (Lond); 2010 Jul; 24(7):1193-8. PubMed ID: 20150927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function.
    Kiss CG; Geitzenauer W; Simader C; Gregori G; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2376-83. PubMed ID: 19136707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments.
    Lommatzsch A; Heimes B; Gutfleisch M; Spital G; Zeimer M; Pauleikhoff D
    Eye (Lond); 2009 Dec; 23(12):2163-8. PubMed ID: 19197318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcome after intravitreal ranibizumab for large, serous pigment epithelial detachment secondary to age-related macular degeneration.
    Arora S; McKibbin M
    Eye (Lond); 2011 Aug; 25(8):1034-8. PubMed ID: 21597485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.
    Bolz M; Michels S; Geitzenauer W; Prager F; Schmidt-Erfurth U
    Br J Ophthalmol; 2007 Jun; 91(6):785-9. PubMed ID: 17050580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration.
    Konstantinidis L; Ambresin A; Zografos L; Mantel I
    Acta Ophthalmol; 2010 Nov; 88(7):736-41. PubMed ID: 19604160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography.
    Lumbroso B; Savastano MC; Rispoli M; Balestrazzi A; Savastano A; Balestrazzi E
    Retina; 2011 Mar; 31(3):553-8. PubMed ID: 21343873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Fung AE; Lalwani GA; Rosenfeld PJ; Dubovy SR; Michels S; Feuer WJ; Puliafito CA; Davis JL; Flynn HW; Esquiabro M
    Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution optical coherence tomography of subpigment epithelial structures in patients with pigment epithelium detachment secondary to age-related macular degeneration.
    Clemens CR; Krohne TU; Charbel Issa P; Helb HM; Kosanetzky N; Lommatzsch A; Holz FG; Eter N
    Br J Ophthalmol; 2012 Aug; 96(8):1088-91. PubMed ID: 22694959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical drainage of a pigment epithelial detachment in neovascular age-related macular degeneration.
    Ernst BJ; Chiranand P; Akduman L
    Retina; 2009 May; 29(5):704-7. PubMed ID: 19430281
    [No Abstract]   [Full Text] [Related]  

  • 15. Reading the signs: Microrips as a prognostic sign for impending RPE tear development.
    Clemens CR; Alten F; Eter N
    Acta Ophthalmol; 2015 Nov; 93(7):e600-2. PubMed ID: 25752471
    [No Abstract]   [Full Text] [Related]  

  • 16. High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.
    Lee DK; Kim SH; You YS; Kwon OW
    Korean J Ophthalmol; 2016 Aug; 30(4):265-71. PubMed ID: 27478353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral-domain versus time domain optical coherence tomography before and after ranibizumab for age-related macular degeneration.
    Querques G; Forte R; Berboucha E; Martinelli D; Coscas G; Soubrane G; Souied EH
    Ophthalmic Res; 2011; 46(3):152-9. PubMed ID: 21389740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.
    Carneiro AM; Silva RM; Veludo MJ; Barbosa A; Ruiz-Moreno JM; Falcão MS; Brandão EM; Falcão-Reis FM
    Ophthalmologica; 2011; 225(2):81-8. PubMed ID: 20881442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration].
    Hajouli N; Hiesch A; Quintyn JC
    J Fr Ophtalmol; 2010 Sep; 33(7):487-92. PubMed ID: 20452090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
    Lalwani GA; Rosenfeld PJ; Fung AE; Dubovy SR; Michels S; Feuer W; Davis JL; Flynn HW; Esquiabro M
    Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.